...
首页> 外文期刊>Canadian Medical Association Journal: Journal de l'Association Medicale Canadienne >The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants
【24h】

The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants

机译:加拿大个人基因组项目:从就职56名参与者的全基因组序列发现

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The Personal Genome Project Canada is a comprehensive public data resource that integrates whole genome sequencing data and health information. We describe genomic variation identified in the initial recruitment cohort of 56 volunteers. METHODS: Volunteers were screened for eligibility and provided informed consent for open data sharing. Using blood DNA, we performed whole genome sequencing and identified all possible classes of DNA variants. A genetic counsellor explained the implication of the results to each participant. RESULTS: Whole genome sequencing of the first 56 participants identified 207 662 805 sequence variants and 27494 copy number variations. We analyzed a prioritized disease-associated data set (n = 1606 variants) according to standardized guidelines, and interpreted 19 variants in 14 participants (25%) as having obvious health implications. Six of these variants (e.g., in BRCA1 or mosaic loss of an X chromosome) were pathogenic or likely pathogenic. Seven were risk factors for cancer, cardiovascular or neurobehavioural conditions. Four other variants — associated with cancer, cardiac or neuro-degenerative phenotypes — remained of uncertain significance because of discrepancies among databases. We also identified a large structural chromosome aberration and a likely pathogenic mitochondrial variant. There were 172 recessive disease alleles (e.g., 5 individuals carried mutations for cystic fibrosis). Pharmacogenomics analyses revealed another 3.9 potentially relevant genotypes per individual.
机译:背景:个人基因组项目加拿大是全面的公共数据资源,集成了全基因组测序数据和健康信息。我们描述了在56个志愿者的初始招募队列中确定的基因组变异。方法:举办志愿者,以获得资格,并提供明智的同意开放数据共享。使用血液DNA,我们进行了全基因组测序,并鉴定了所有可能的DNA变体类别。遗传辅导员解释了每个参与者对结果的影响。结果:前56名参与者的全基因组测序鉴定了207 662 805序列变体和27494份拷贝数变异。我们根据标准化指南分析了优先型疾病相关数据集(n = 1606变体),并在14名参与者(25%)中解释了19种变种,具有明显的健康影响。这些变体中的六种(例如,在BRCA1或X染色体的马赛克损失中)是致病的或可能的致病性的。七是癌症,心血管或神经外禽病的危险因素。另外四种 - 与癌症,心脏或神经退化表型相关的其他变体 - 由于数据库之间的差异差异而仍然不确定。我们还鉴定了大型结构染色体畸变和可能的致病线粒体变体。有172个隐性疾病等位基因(例如,5个个体患有囊性纤维化的突变)。药癌组学分析显示另外3.9个潜在的相关基因型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号